Does INTERFERON BETA-1A Cause Pulmonary arterial hypertension? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Pulmonary arterial hypertension have been filed in association with INTERFERON BETA-1A (Avonex). This represents 0.1% of all adverse event reports for INTERFERON BETA-1A.
55
Reports of Pulmonary arterial hypertension with INTERFERON BETA-1A
0.1%
of all INTERFERON BETA-1A reports
2
Deaths
19
Hospitalizations
How Dangerous Is Pulmonary arterial hypertension From INTERFERON BETA-1A?
Of the 55 reports, 2 (3.6%) resulted in death, 19 (34.5%) required hospitalization, and 6 (10.9%) were considered life-threatening.
Is Pulmonary arterial hypertension Listed in the Official Label?
Yes, Pulmonary arterial hypertension is listed as a known adverse reaction in the official FDA drug label for INTERFERON BETA-1A.
What Other Side Effects Does INTERFERON BETA-1A Cause?
Multiple sclerosis relapse (5,931)
Influenza like illness (4,475)
Memory impairment (3,468)
Multiple sclerosis (3,412)
Fatigue (3,164)
Fall (3,128)
Gait disturbance (3,031)
Death (2,766)
Pain (2,692)
Headache (2,533)
What Other Drugs Cause Pulmonary arterial hypertension?
TREPROSTINIL (3,240)
MACITENTAN (2,390)
AMBRISENTAN (1,965)
SELEXIPAG (1,387)
EPOPROSTENOL (1,055)
BOSENTAN (778)
TADALAFIL (680)
SILDENAFIL (487)
RIOCIGUAT (436)
ILOPROST (284)
Which INTERFERON BETA-1A Alternatives Have Lower Pulmonary arterial hypertension Risk?
INTERFERON BETA-1A vs INTERFERON BETA-1B
INTERFERON BETA-1A vs INTERFERON GAMMA
INTERFERON BETA-1A vs INTERFERON GAMMA-1B
INTERFERON BETA-1A vs INVEGA
INTERFERON BETA-1A vs INVEGA SUSTENNA